GlassScriptPhysician profile
Kelli M Walker
NPI 1497211635
$805.95
in general payments reported to CMS, 2019-2025
19 companies · $134 in 2025
The $134 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $241 · 2022: $84.39 · 2023: $192 · 2024: $154 · 2025: $134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $480.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $480.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aurinia Pharma U.S., INC. | $121.91 | 2021 | |
| Boston Scientific Corporation | $116.16 | 2023 | Spyscope Ds |
| Mallinckrodt Hospital Products INC. | $94.99 | 2021 | |
| La Jolla Pharmaceutical Company | $78.32 | 2023-2025 | Xerava, Zevtera, Giapreza |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $60.37 | 2022-2025 | Lifevest |
| Takeda Pharmaceuticals U.S.A., INC. | $56.24 | 2024 | Entyvio |
| Akebia Therapeutics INC | $37.30 | 2022 | |
| Phathom Pharmaceuticals, INC. | $31.57 | 2024 | Voquezna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.28 | 2024 | Trulance, Xifaxan |
| Tetraphase Pharmaceuticals, INC. | $28.23 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $22.16 | 2025 | |
| Abbvie INC. | $19.92 | 2025 | |
| Alexion Pharmaceuticals, INC. | $17.83 | 2022 | |
| Ironwood Pharmaceuticals, INC | $17.37 | 2024 | |
| Abbott Laboratories | $17.18 | 2024 | Eterna |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $16.00 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $14.82 | 2022 | |
| Opko Pharmaceuticals, LLC | $12.64 | 2021 | |
| Medtronic, INC. | $11.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelli Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.